Pink Sheet Podcast: What We Learned From The First Batch Of Medicare Negotiated Drug Prices

Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.

Pink Sheet podcast
Stakeholders are waiting for more information from round one of the Medicare price negotiation program. • Source: Citeline/Shutterstock

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Senior Editor Cathy Kelly discuss what we learned, and did not learn, from the 15 August release of the first batch of drug prices negotiated by the US Centers for Medicare and Medicaid Services, as well as its impact on the program and industry going forward.

Open Media

More from Medicare

More from Government Payers